Driving Breakthroughs in Precision Oncology
Stage4Hope donates all funds remaining after essential operating costs each year directly to cancer research. These dollars are awarded as grants of $100,000 or more to leading investigators at top cancer centers whose work can quickly translate into better treatments for patients.
Current Focus Areas
Precision Oncology
Putting the right drug in the right patient at the right time.
Targeted Therapies
Advancing next-generation inhibitors and antibody-drug conjugates for ROS1, ALK, RET, TRK, EGFR, and other gene-driven cancers.
Lung Cancer Priority
Addressing unmet needs in advanced non-small cell lung cancer, especially ROS1-positive disease.
Clinical Trial Acceleration
Expanding access to early-phase clinical trials at leading centers.
Partnership Highlight: Memorial Sloan Kettering (MSK)
Application Process
Stage4Hope currently awards research grants on a strategic, invitation-only basis, reviewed and approved by our Board with guidance from external experts.
Our vision is to expand this program to fund a growing number of transformative projects every year.
How You Can Help
-
Give to Research
Every gift helps fuel $100,000+ investigator grants.
-
Partner With Us
Donors can direct major gifts toward groundbreaking projects at top cancer centers.
-
Build the Future
With your support, Stage4Hope can expand the number of grants awarded each year and accelerate breakthroughs.